Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-26 @ 1:32 AM
NCT ID:
NCT01715233
Group ID:
EG000
Title:
Metastatic Esophageal, Gastroesophageal & Gastric Cancer
Description:
Patients received modified Docetaxel 40mg/m2, Leucovorin 400mg/m2 and Fluorouracil 400mg/m2 on day 1, Fluorouracil 1000mg/m2 per day on days 1 and 2 and Cisplatin 40mg/m2 (or Carboplatin) on day 3 in Patients With Metastatic Esophageal, Gastroesophageal And Gastric Cancer.
Docetaxel: Modified Docetaxel 40mg/m2 on Day 1
Leucovorin: Leucovorin 400mg/m2 on Day 1
Fluorouracil: Fluorouracil 400mg/m2 on Day 1 Fluorouracil 1000mg/m2/day on Days 1 and 2
Cisplatin: Cisplatin (or Carboplatin) 40mg/m2 on Day 3
Deaths Number Affected:
19
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
21
Other Number Affected:
18
Other Number At Risk:
21
Study:
NCT01715233
Results Section:
NCT01715233
Adverse Events Module:
NCT01715233